2006 1-6

Company Expands Sales Channels to Increase Sales Through Deployment of Proven Solutions

RESEARCH TRIANGLE PARK, NC (June 19, 2006) —BioMachines Inc., a biotech company that develops, manufactures and sells advanced automation tools to accelerate drug discovery and development, today announced the signing of an exclusive distribution agreement with CapitalBio Corporation of Beijing, China. With the signing of this agreement, BioMachines has expanded its sales channel beyond North America and Europe and into China, Taiwan and Hong Kong.

CapitalBio Corporation today announced the appointment of Dr. Ming-Wei Wang as a member of its Business Advisory Board.

Beijing, China, May, 15th 2006 CapitalBio Corporation today announced the appointment of Mingxian Huang, Ph.D., as CSO of Chemistry.